PUMA BIOTECHNOLOGY, INC. Lessee, Operating Lease, Liability, to be Paid, after Year Five
PUMA BIOTECHNOLOGY, INC. (PBYI) had Lessee, Operating Lease, Liability, to be Paid, after Year Five of $951.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive · last filed 2026-02-26
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $951.00K.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $1.51M.
- 2020-03-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $7.49M.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $7.49M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2025-12-31 | $951.00K 10-K · filed 2026-02-26 |
| 2020-12-31 | $1.51M 10-K · filed 2021-03-01 |
| 2020-03-31 | $7.49M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $7.49M 10-K · filed 2020-02-28 |
| 2019-09-30 | $13.30M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $13.30M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $13.30M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |